Call us : +91-11-2874-2874   |   Email us : info@translumina.in

Products

Products

When it comes to delivering the best to your patients Quality and Clinical Evidence matters.Yukon Choice PC is a combination of Sirolimus, Biodegradable Polymer Resomer R202S coated abluminally on the Microporous Stent surface with top coat of Shellac Resin.Yukon Choice PC is the first product where a proven technology of Drug Eluting Stent has been sourced from Europe and manufactured in India using international standards, high end machines and layouts created as per the European Guidelines

Yukon Choice PC is a third generation Sirolimus eluting Stent System that combines the synergistic effect of surface modification and biodegradable polymer to create optimum release.

  1. Overview
  2. Specifications
  3. Video
  4. Download

Yukon Choice PC is a combination of Sirolimus, Biodegradable Polymer Resomer R202S coated abluminally on the Microporous Stent surface with top coat of Shellac Resin. YUKON Choice PC’s Stent surface is coated abluminally with patented technology of German Heart Centre with no drug or polymer on the luminal side of the Stent for enhanced safety which ensures faster endotheliazation.

At 4 years follow-up Yukon Choice PC shows reduction of risk by 50% in definite Stent Thrombosis and by 78% in Very Late Stent Thrombosis compared to First generation DES without compromising on Efficacy.

Salient Features

Technical Specifications of the Stent

Description Specification
Crossing Profle 0.035” / 0.89 mm
Strut Thickness 0,0034” / 87 um
Metallic Surface Area - No Foreshortening 16 - 18%
Baloon Marker Material Platinum / Iridium
 

Excellent Clinical Results

 

Safety of BMS Platform

The microporous surface of Yukon Choice PC is well studied for its efficacy and safety when compared to electropolished surface. Microporous surface shows a trend reduced rate of binary restenosis will equivalent safety, which proves that it is safeand feasible to release drug from a microporous surface

 

Efficacy

ISAR TEST 4 is the first prospective randomized trial which compared 3 DES i.e Yukon Choice PC, Xience and Cypher for their efficacy & safety. 

 

Long Term Safety

One of the largest meta-analysis involving more than 4,000 patient, which compared biodegradable polymer based DES with permanent polymer based DES demonstrated the excellent safety profile of Yukon Choice Flex. At 4 years follow-up, Yukon Choice Flex shows reduction of risk by 50% in definite Stent Thrombosis and by 78% in Very Late Stent Thrombosis(VLST) compared to First generation DES without comparomising on efficacy..